Panacea Biotec Pharma Limited - Company Profile

Q: Who are the current directors of Panacea Biotec Pharma Limited?

The current directors of Panacea Biotec Pharma Limited are Ankesh Jain, Rajesh Jain, Manjula Upadhyay, Narotam Kumar Juneja, Rajesh Jain, Sanjay Trehan.

It is a pharma public limited company based in New Delhi, Delhi, India, established in 2019.

2019 New Delhi, Delhi, India Active

Last Updated: January 11, 2026

Access Report

About Panacea Biotec Pharma Limited

Panacea Biotec Pharma Limited, a active public limited company, was established on 22 March 2019 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299DL2019PLC347566. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹60.00 Cr and a paid-up capital of ₹1.00 M.

Employing 749 professional, Its leadership includes Ankesh Jain (Whole-Time Director), Rajesh Jain (Director), Manjula Upadhyay (Director). Past directors included Shantanu Yeshwant Nalavadi, Ankesh Jain, Krishna Murari Lal. It holds no open charges and ₹1,618.44 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-1 Extension/A-27, Mohan Co-Operative Industrial Estate, Mathura Road, New Delhi, Delhi, 110044.

Company Details

CIN/LLPIN
U24299DL2019PLC347566
Registration Number
347566
Incorporation Date
22 March 2019
Authorized Capital
₹60.00 Cr
Paid-Up Capital
₹1.00 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 60.00 Cr as on 11-01-2026
Paid Up Capital ₹ 1.00 M as on 11-01-2026
Company Age 6 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 1,618.44 Cr as on 11-01-2026
Revenue Growth **** -46.22% (FY 2023)
Profit Growth **** -95.54% (FY 2023)
Ebitda **** -217.12% (FY 2023)
Net Worth 12.60% (FY 2023)
Total Assets -42.49% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Panacea Biotec Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Panacea Biotec Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ankesh Jain	Whole-Time Director	22 Mar 2019	Current
Rajesh Jain	Director	12 Nov 2024	Current
Manjula Upadhyay	Director	23 Jul 2021	Current
Narotam Kumar Juneja	Whole-Time Director	01 Apr 2022	Current
Rajesh Jain	Managing Director	22 Mar 2019	Current
Sanjay Trehan	Whole-Time Director	13 Feb 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Nominee Director	10 Dec 2020	Past
Pramod Abcsdd	Director	31 May 2024	Past
Pramod Abcsdd	Additional Director	11 Dec 2020	Past
Pramod Abcsdd	Additional Director	05 Dec 2024	Past
Pramod Abcsdd	Additional Director	30 Jul 2021	Past
Pramod Abcsdd	Additional Director	01 Apr 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Panacea Biotec Pharma.

Panacea Biotec Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.22% decrease. The company also saw a substantial fall in profitability, with a 95.54% decrease in profit. The company's net worth Soared by an impressive increase of 12.6%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-46.22%

*******

Revenue from Operations

*******

-52.06%

*******

Total Assets

*******

-42.49%

*******

Profit or Loss

*******

-95.54%

*******

Net Worth

*******

12.60%

*******

EBITDA

*******

-217.12%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Panacea Biotec Pharma?

In 2023, Panacea Biotec Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹16,184,448,363.00

Charges Breakdown by Lending Institutions

Others : 1618.44 Cr

Latest Charge Details

Date	Lender	Amount	Status
01 Feb 2020	Others	₹754.44 Cr	Satisfied
06 Apr 2019	Others	₹864.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Panacea Biotec Pharma?

Panacea Biotec Pharma has a workforce of 749 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Panacea Biotec Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Biotec Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Panacea Biotec Pharma

Recent Activity within the Organization

Annual General Meeting

Panacea Biotec Pharma Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
29 Sep 2025
Balance Sheet

Panacea Biotec Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
31 Mar 2025
Director Appointment

Sanjay Trehan was appointed as a Whole-time director was appointed as a Whole-time director on 13 Feb 2025 & has been associated with this company since 11 months 27 days . was recorded as a recent event.
13 Feb 2025
Director Appointment

The activity Rajesh Jain was appointed as a Director was appointed as a Director on 12 Nov 2024 & has been associated with this company since 1 year 2 months . was completed.
12 Nov 2024
Director Appointment

The activity Narotam Kumar Juneja was appointed as a Whole-time director was appointed as a Whole-time director on 01 Apr 2022 & has been associated with this company since 3 years 10 months . was completed.
01 Apr 2022
Charges

Progress on A charge registered on 01 Feb 2020 via Charge ID 100332250 with Others was fully satisfied on 03 Mar 2022. was documented.
03 Mar 2022

Explore recent activity and updates - View Recent Activity